Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
01 3SANOFI-AVENTIS GROUPE
02 6Sanofi Winthrop Industrie
03 2Sanofi-Aventis (Switzerland) Sa
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info :
Registration Country : Italy
Brand Name : Lyxumia
Dosage Form : Lixisenatide 10Mcg 3Ml 1 Units Parenteral Use
Dosage Strength : 1 cartridge SC in preriemp pen 3 ml 10 mcg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info :
Registration Country : Italy
Brand Name : Lyxumia
Dosage Form : Lixisenatide 20Mcg 3Ml 2 Units Parenteral Use
Dosage Strength : 2 cartridges SC in preriemp pen 3 ml 20 mcg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info :
Registration Country : Italy
Brand Name : Lyxumia
Dosage Form : Lixisenatide 10Mcg+20Mcg 3Ml 1+1 Units Parenteral Use
Dosage Strength : 1 cartridge SC in preriemp pen 3 ml 10 mcg + 1 cartridge SC in preriemp pen 3 ml 20 mcg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info : Allowed
Registration Country : Switzerland
Insulin Glargine; Lixisenatide
Brand Name : Suliqua
Dosage Form : Injectable Solution
Dosage Strength : 100mg;50mg
Packaging :
Approval Date : 05/10/2017
Application Number : 66283
Regulatory Info : Allowed
Registration Country : Switzerland
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info : Allowed
Registration Country : Switzerland
Insulin Glargine; Lixisenatide
Brand Name : Suliqua
Dosage Form : Injectable Solution
Dosage Strength : 100mg;33mg
Packaging :
Approval Date : 05/10/2017
Application Number : 66283
Regulatory Info : Allowed
Registration Country : Switzerland
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info : Approved
Registration Country : Sweden
Insulin Glargine; Lixisenatide
Brand Name : Suliqua
Dosage Form : Solution For Injection
Dosage Strength : 100IU/ml;33mcg/ml
Packaging :
Approval Date : 11/01/2017
Application Number : 20160309000010
Regulatory Info : Approved
Registration Country : Sweden
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info : Approved
Registration Country : Sweden
Insulin Glargine; Lixisenatide
Brand Name : Suliqua
Dosage Form : Solution For Injection
Dosage Strength : 100IU/ml;50mcg/ml
Packaging :
Approval Date : 11/01/2017
Application Number : 20160309000027
Regulatory Info : Approved
Registration Country : Sweden
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info : Authorized
Registration Country : Spain
Insulin Glargine; Lixisenatide
Brand Name : Suliqua
Dosage Form : Injectable Solution
Dosage Strength : 100UNIT; 33 MCG
Packaging :
Approval Date : 2017-02-03
Application Number : 1161157004
Regulatory Info : Authorized
Registration Country : Spain
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info : Authorized
Registration Country : Spain
Insulin Glargine; Lixisenatide
Brand Name : Suliqua
Dosage Form : Injectable Solution
Dosage Strength : 100UNIT; 50MCG
Packaging :
Approval Date : 2017-02-03
Application Number : 1161157002
Regulatory Info : Authorized
Registration Country : Spain
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info : Authorized
Registration Country : Spain
Brand Name : Lyxumia
Dosage Form : Injectable Solution
Dosage Strength : 10MCG
Packaging :
Approval Date : 2013-02-13
Application Number : 12811001
Regulatory Info : Authorized
Registration Country : Spain
